Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.

Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Abstract Text:

    e aiharaE Aihara,s hayashiS Hayashi,k amagaseK Amagase,s katoS Kato,k takeuchiK Takeuchi,e aiharaE Aihara,s hayashiS Hayashi,k amagaseK Amagase,s katoS Kato,k takeuchiK Takeuchi,

    We examined the effect of rebamipide, an antiulcer drug, on the mucosal irritative and the healing impairment action of alendronate in rat stomachs. Male SD rats were used to examine the effect of rebamipide in the following 3 experiments. 1) Alendronate applied topically to the chambered stomach under urethane anaesthesia produced a decrease in the transmucosal potential difference and an increase of gastric mucosal blood flow and luminal acid loss, resulting in slight damage to the mucosa. Pretreatment with rebamipide for 3 days had no effect on the changes induced by alendronate. 2) Oral administration of alendronate caused non-haemorrhagic lesions in the stomach within 4 hr. Rebamipide, given either as a single p. o. injection or repeatedly for 7 days, did not significantly affect the lesions induced by alendronate. 3) Alendronate, given p. o. once daily for 1 week, markedly delayed the healing of acetic acid-induced gastric ulcers with the suppression of basic fibroblast growth factor (bFGF) expression. Rebamipide, given twice daily for 7 days, significantly promoted the delayed ulcer healing caused by alendronate, with the concomitant recovery of bFGF expression. These results suggest that rebamipide does not affect the direct irritating action of alendronate in the gastric mucosa, but this agent antagonizes the healing impairment action of alendronate by counteracting the downregulation of bFGF expression in the ulcerated mucosa.

    Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Publishing Authors By Initials

    e aiharaE Aihara,s hayashiS Hayashi,k amagaseK Amagase,s katoS Kato,k takeuchiK Takeuchi,e aiharaE Aihara,s hayashiS Hayashi,k amagaseK Amagase,s katoS Kato,k takeuchiK Takeuchi,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Inflammopharmacology

    VOLUME: 15

    Page Numbers: 196-202

    Journal Abbreviation:

    ISSN: 0925-4692

    DAY: 18

    MONTH: Oct

    YEAR: 2007

    Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9112626

    Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs.

    AFFILIATION: Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto 607-8414, Japan.

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Inflammopharmacology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Prophylactic effect of rebamipide against the irritative and healing impairment actions of alendronate in rat stomachs Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News